1.1. Introduction: In recent years, many new antidiabetic drugs have been developed. One class of these new antidiabetic drugs are sodium-glucose cotransporter 2 inhibitors (SGLT2i). SGLT2i are associated with an increased risk of euglycemic ketoacidosis (euDKA).
Statin-induced immune-mediated necrotizing myopathy (IMNM) is an exceedingly rare complication of statin use, which should be suspected in the patient with elevated CPK levels, symmetric proximal muscle weakness and persistence of symptoms despite discontinuation of statin therapy.
Impact Factor 4.787*
Annals of Clinical and Medical Case Reports® is an esteemed and zealous in publishing various scientific and medical journals which acts as a shell that provides latest research information for all the researchers across the world.
Address: 500 N. Rainbow Blvd, Suite 300, Las Vegas, Nevada 89107 USA.
Email: submission@acmcasereport.us
Phone: +1 7755157689
You cannot copy content of this page